Assesment of Effectiveness and side effects: Case Report forms, Quality of life questionaire
Study summary
The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
Histologically confirmed lymphoma according to WHO
* Patient consent
* Patient age ≥18 years.
* Presence of the need for mediastinal radiotherapy and the presumed benefit of mediastinal radiotherapy using protons in comparison to photon radiation (e.g. improved heart, lungs, and breast protection compared to photon radiation).
* Ability of the patient to give consent
Exclusion Criteria:
Age \<18 years
* Non-consent of the patient to the disclosure of his data
* Cancellation of the patient's participation in the study
Primary outcome measure(s)
Acquisition and documentation of a mediastinal PT and the corresponding follow-up data — From date of written informed consent until the date of death from any cause, assessed up to 100 month Effectiveness and side effects of proton radiotherapy
Trial sites (1)
Facility
City
Region
Status
University Hospital Heidelberg
Heidelberg
Germany
Recruiting
More University Hospital Heidelberg trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.